Work

A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding or Stable Disease after Induction Chemotherapy: A Trial of the Eastern Cooperative Oncology Group (E1500)

Year: 2007

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e318155a439

Authors: Kishan J. Pandya, Suzanne Dahlberg, Manuel Hidalgo, Roger B. Cohen, Martin W. Lee, Joan H. Schiller, David H. Johnson

Institutions: University of Rochester Medicine, University of Rochester, Dana-Farber Cancer Institute, Johns Hopkins University, Fox Chase Cancer Center, Park Nicollet Health Services, The University of Texas Southwestern Medical Center, Vanderbilt University

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: G1042980396, G1257575315, ECOG Statistical Office Data Management Grant, G1422427855, G3210846400, Eastern Cooperative Oncology Group, G4412485521, Southwest Oncology Group, G5765316850, Eastern Cooperative Oncology Group, G721629745, Eastern Cooperative Oncology Group, EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES, ECOG Statistical Office, Eastern Cooperative Oncology Group Operations Office, G964706321

OpenAlex ID: W2058237771

FWCI: 6.242

Cites: 16

Cited by: 141

Related to: 10